Skip to content

Author

Weronika Piekarska

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Aug 2026

COBENFY - A NEW ANTIPSYCHOTIC DRUG

Coenfy (xanomeline–trospium), approved by the U.S. Food and Drug Administration in 2024, represents the first antipsychotic with a non-dopaminergic mechanism of action and expands current treatment options by introducing a novel cholinergic therapeutic strategy.

Gabriela Majchrowicz, Mikołaj Jońca, Natasza Kurys et al. · 0 citations
Review Open access Aug 2026

THERAPY FOR ALZHEIMER’S DISEASE - FOCUS ON LECANEMAB

Alzheimer’s disease (AD) is a chronic, progressive neurodegenerative disorder and the leading cause of dementia worldwide, with prevalence increasing due to population aging. It is characterized by cognitive decline, functional impairment, and significant public health burden. Pathophysiology involves a complex interpl...

Mikołaj Jońca, Gabriela Majchrowicz, Natasza Kurys et al. · 0 citations
Review Open access Jul 2026

Underdiagnosis of ADHD in Women as a Hidden Hurdle and Its Consequences for Functioning in Adulthood— A Literature Review

Underdiagnosis of ADHD in women remains a significant clinical and public health issue, and greater awareness of sex-specific symptom presentation and improved diagnostic strategies are essential to prevent long-term psychosocial consequences and improve quality of life in affected women.

N. Samp, P. Trzepizur, Kamila Zera et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.